Mingjian Chen

Nov 14, 2024 | pubs.acs.org | Lin He |Yan Zhou |Min Zhang |Mingjian Chen

Oct 28, 2024 | dx.doi.org | Dan Wang |Le Tang |Mingjian Chen |Zhaojian Gong

Sep 27, 2024 | pubs.rsc.org | Le Tang |Mingjian Chen |Dan Wang

Doxorubicin and iron-doped mesoporous silica nanoparticles for chemodynamic therapy and chemotherapy of breast cancer† Breast cancer is one of the most prevalent malignancies, necessitating the exploration of more effective synergistic treatment strategies to overcome the limitations of conventional therapies. Chemodynamic therapy (CDT) is an innovative antitumor approach that can be combined with chemotherapy to achieve potent synergistic effects.

Jun 30, 2024 | onlinelibrary.wiley.com | Jiarong Zhang |Mingjian Chen |Yuxin Yang |Ziqi Liu

CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. REFERENCES , , , , , , & (2019). Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice. PLoS One, 14(5), e0217276. , , & (2016). From Krebs to clinic: Glutamine metabolism to cancer therapy. Nature Reviews Cancer, 16(10), 619–634. , , , , , , , , , , , , , & (2010). FcRγ activation regulates inflammation-associated squamous carcinogenesis.

Jun 24, 2023 | pericles.pericles-prod.literatumonline.com | Mingjian Chen |Yuxin Yang |Le Tang |Shuyi He

Research Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.